Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- Latest filing
- Aug 14, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 17, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 121
- −37 vs. Q1 2021
- Portfolio value
- $1.05B
- −$37.4M (−3.4%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AZNAstraZeneca PLC | SPONSORED ADR | 1,147,673 | $68.7M | 6.5% | +187,200+19.5% | Added | History |
| JNJJohnson & Johnson | Stock | 405,608 | $66.8M | 6.4% | −48,292−10.6% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 772,601 | $60.1M | 5.7% | −36,207−4.5% | Reduced | History |
| SNYSanofi | SPONSORED ADR | 843,400 | $44.4M | 4.2% | −154,500−15.5% | Reduced | History |
| GNRCGenerac Holdings Inc. | Stock | 104,363 | $43.3M | 4.1% | −1,300−1.2% | Reduced | History |
| LLYEli Lilly & Co | Stock | 181,895 | $41.7M | 4.0% | −247,305−57.6% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 366,194 | $41.2M | 3.9% | −233,306−38.9% | Reduced | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 518,611 | $19.6M | 1.9% | +21,475+4.3% | Added | History |
| NICENICE Ltd. | SPONSORED ADR | 76,786 | $19.0M | 1.8% | +37,305+94.5% | Added | History |
| EPIXESSA Pharma Inc. | COM NEW | 648,303 | $18.5M | 1.8% | +179,062+38.2% | Added | History |
| KRNTKornit Digital Ltd. | SHS | 147,793 | $18.4M | 1.7% | −588−0.4% | Reduced | History |
| MSFTMicrosoft Corp | Stock | 67,536 | $18.3M | 1.7% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 868,886 | $18.1M | 1.7% | +151,135+21.1% | Added | History |
| ZLABZai Lab Ltd | ADR | 97,946 | $17.3M | 1.6% | +32,158+48.9% | Added | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 195,117 | $16.1M | 1.5% | +57,445+41.7% | Added | History |
| FATEFate Therapeutics Inc | COM | 165,299 | $14.3M | 1.4% | +55,492+50.5% | Added | History |
| LPSNLiveperson Inc | COM | 225,000 | $14.2M | 1.4% | −35,000−13.5% | Reduced | History |
| AMZNAmazon Com Inc | Stock | 4,061 | $14.0M | 1.3% | +1,300+47.1% | Added | History |
| PTGXProtagonist Therapeutics, Inc | COM | 302,965 | $13.6M | 1.3% | +100,831+49.9% | Added | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 4,080,673 | $12.9M | 1.2% | −96,485−2.3% | Reduced | History |
| AUDCAudiocodes Ltd | ORD | 385,194 | $12.7M | 1.2% | −90,430−19.0% | Reduced | History |
| KYMRKymera Therapeutics, Inc. | COM | 259,895 | $12.6M | 1.2% | +12,368+5.0% | Added | History |
| VRNSVaronis Systems Inc | COM | 218,013 | $12.6M | 1.2% | +79,338+57.2% | Added | History |
| ONCROncorus, Inc. | COM | 893,548 | $12.3M | 1.2% | −9,563−1.1% | Reduced | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 706,294 | $12.0M | 1.1% | +706,294 | New | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 634,088 | $12.0M | 1.1% | +349,864+123.1% | Added | History |
| Affimed N VN01045108 | COM | 1,276,702 | $10.9M | 1.0% | +257,737+25.3% | Added | – |
| ALXOAlx Oncology Holdings Inc | COM | 192,728 | $10.5M | 1.0% | +62,377+47.9% | Added | History |
| TWLOTwilio Inc | CL A | 26,500 | $10.4M | 1.0% | +26,500 | New | History |
| Therapeutics Acquisition Cor88339T103 | COM CL A | 1,009,497 | $10.4M | 1.0% | +289,497+40.2% | Added | – |
| IOVAIovance Biotherapeutics, Inc. | COM | 378,642 | $9.85M | 0.9% | +378,642 | New | History |
| CSTECaesarstone Ltd. | ORD SHS | 644,146 | $9.51M | 0.9% | +108,998+20.4% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 547,187 | $9.39M | 0.9% | −90,906−14.2% | Reduced | History |
| METAMeta Platforms, Inc. | Stock | 27,000 | $9.39M | 0.9% | +27,000 | New | History |
| SEDGSolaredge Technologies, Inc. | COM | 32,200 | $8.90M | 0.8% | +32,200 | New | History |
| NTLAIntellia Therapeutics, Inc. | COM | 52,550 | $8.51M | 0.8% | +52,550 | New | History |
| BIIBBiogen Inc. | COM | 23,995 | $8.31M | 0.8% | +17,195+252.9% | Added | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 832,878 | $8.24M | 0.8% | 00.0% | Unchanged | History |
| NAUTNautilus Biotechnology, Inc. | COM | 800,000 | $8.08M | 0.8% | +800,000 | New | History |
| NKTXNkarta, Inc. | COM | 252,478 | $8.00M | 0.8% | +151,472+150.0% | Added | History |
| STTKShattuck Labs, Inc. | COM | 274,214 | $7.95M | 0.8% | +133,549+94.9% | Added | History |
| ONTOOnto Innovation Inc. | COM | 107,548 | $7.86M | 0.7% | −17,452−14.0% | Reduced | History |
| STOKStoke Therapeutics, Inc. | COM | 233,135 | $7.85M | 0.7% | +82,406+54.7% | Added | History |
| DYNDyne Therapeutics, Inc. | COM | 369,714 | $7.78M | 0.7% | −80,350−17.9% | Reduced | History |
| MRTXMirati Therapeutics, Inc. | COM | 47,309 | $7.64M | 0.7% | +17,530+58.9% | Added | History |
| BCLS Acquisition CorpG0904B105 | COM CL A | 687,900 | $7.24M | 0.7% | 00.0% | Unchanged | – |
| ONCBeOne Medicines Ltd. | ADR | 20,900 | $7.17M | 0.7% | 00.0% | Unchanged | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 334,794 | $7.03M | 0.7% | +132,810+65.8% | Added | History |
| VRNTVerint Systems Inc | COM | 150,000 | $6.76M | 0.6% | +150,000 | New | History |
| ALTAltimmune, Inc. | COM NEW | 683,395 | $6.73M | 0.6% | +683,395 | New | History |
| NRIXNurix Therapeutics, Inc. | COM | 244,157 | $6.48M | 0.6% | +29,081+13.5% | Added | History |
| MRUSMerus N.V. | COM | 286,506 | $6.04M | 0.6% | +209,514+272.1% | Added | History |
| RACBResearch Alliance Corp. II | COM CL A | 600,000 | $6.00M | 0.6% | 00.0% | Unchanged | History |
| ORTXOrchard Therapeutics plc | ADS | 1,366,564 | $6.00M | 0.6% | 00.0% | Unchanged | History |
| ATERAterian, Inc. | Equity | 399,999 | $5.85M | 0.6% | +399,999 | New | History |
| STROSutro Biopharma, Inc. | COM | 294,825 | $5.48M | 0.5% | 00.0% | Unchanged | History |
| ALLTAllot Ltd. | SHS | 276,187 | $5.48M | 0.5% | −144,018−34.3% | Reduced | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 173,891 | $5.37M | 0.5% | +6,092+3.6% | Added | History |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 500,000 | $5.36M | 0.5% | 00.0% | Unchanged | History |
| QUREuniQure N.V. | SHS | 172,000 | $5.30M | 0.5% | +172,000 | New | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 801,256 | $5.24M | 0.5% | 00.0% | Unchanged | History |
| FVRRFiverr International Ltd. | ORD SHS | 21,500 | $5.21M | 0.5% | +21,500 | New | History |
| INBXInhibrx Biosciences, Inc. | COM | 189,083 | $5.20M | 0.5% | +74,440+64.9% | Added | History |
| CRISCuris Inc | COM NEW | 588,264 | $4.75M | 0.5% | −297,574−33.6% | Reduced | History |
| CVRXCVRx, Inc. | COM | 150,000 | $4.20M | 0.4% | +150,000 | New | History |
| RUNSunrun Inc. | COM | 72,000 | $4.02M | 0.4% | +72,000 | New | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 46,350 | $3.89M | 0.4% | −8,612−15.7% | Reduced | History |
| SGTXSigilon Therapeutics, Inc. | COM | 360,239 | $3.87M | 0.4% | −2,000−0.6% | Reduced | History |
| BEAMBeam Therapeutics Inc. | COM | 28,425 | $3.66M | 0.3% | +28,425 | New | History |
| PLTKPlaytika Holding Corp. | COM | 150,000 | $3.58M | 0.3% | +150,000 | New | History |
| ARKOARKO Corp. | COM | 369,875 | $3.40M | 0.3% | −38,125−9.3% | Reduced | History |
| ANNXAnnexon, Inc. | COM | 148,318 | $3.34M | 0.3% | +148,318 | New | History |
| Eucrates Biomedical Acqu CorG3141W106 | SHS | 329,025 | $3.24M | 0.3% | +25,000+8.2% | Added | – |
| ISEEIVERIC bio, Inc. | COM | 500,000 | $3.15M | 0.3% | +500,000 | New | History |
| RPTXRepare Therapeutics Inc. | COM | 100,391 | $3.13M | 0.3% | −147,709−59.5% | Reduced | History |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 233,850 | $3.04M | 0.3% | +21,250+10.0% | Added | – |
| Bio Green Med Solution, Inc.23254L603 | COM | 508,322 | $3.01M | 0.3% | 00.0% | Unchanged | – |
| NEXNNexxen International Ltd. | ADS | 150,000 | $2.98M | 0.3% | +150,000 | New | History |
| VINCVincerx Pharma, Inc. | COM NEW | 227,450 | $2.96M | 0.3% | +133,742+142.7% | Added | History |
| SSentinelOne, Inc. | CL A | 68,400 | $2.91M | 0.3% | +68,400 | New | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 84,074 | $2.87M | 0.3% | +40,718+93.9% | Added | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 292,194 | $2.86M | 0.3% | −7,806−2.6% | Reduced | – |
| ARGXArgenx SE | SPONSORED ADR | 9,249 | $2.79M | 0.3% | 00.0% | Unchanged | History |
| KRROKorro Bio, Inc. | COM | 275,160 | $2.74M | 0.3% | +275,160 | New | History |
| CYTCyteir Therapeutics, Inc. | COM | 125,000 | $2.67M | 0.3% | +125,000 | New | History |
| PRGOPERRIGO Co plc | SHS | 52,500 | $2.41M | 0.2% | +52,500 | New | History |
| TWSTTwist Bioscience Corp | COM | 18,000 | $2.40M | 0.2% | +18,000 | New | History |
| Cerevel Therapeutics HLDNG I15678U102 | *W EXP 06/09/202 | 165,295 | $2.38M | 0.2% | −1,037−0.6% | Reduced | – |
| IPSCCentury Therapeutics, Inc. | COM | 80,000 | $2.35M | 0.2% | +80,000 | New | History |
| LVTXLAVA Therapeutics NV | SHS | 215,359 | $2.34M | 0.2% | +1,465+0.7% | Added | History |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 100,000 | $2.27M | 0.2% | +100,000 | New | History |
| Turmeric Acquisition CorpG9127T108 | CL A | 219,440 | $2.17M | 0.2% | 00.0% | Unchanged | – |
| JYACJiya Acquisition Corp. | COM CL A | 199,028 | $1.98M | 0.2% | 00.0% | Unchanged | History |
| HYPRHyperfine, Inc. | CL A SHS | 200,000 | $1.97M | 0.2% | 00.0% | Unchanged | History |
| Healthcare Capital Corp42228C200 | UNIT 12/31/2025 | 196,610 | $1.96M | 0.2% | −203,390−50.8% | Reduced | – |
| ALDXAldeyra Therapeutics, Inc. | COM | 150,000 | $1.70M | 0.2% | +150,000 | New | History |
| WIXWix.com Ltd. | SHS | 5,700 | $1.66M | 0.2% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 51,000 | $1.49M | 0.1% | +51,000 | New | History |
| OMICSingular Genomics Systems, Inc. | COM | 53,867 | $1.48M | 0.1% | +53,867 | New | History |
| Clarim Acquisition Corp18049C207 | UNIT 99/99/9999 | 148,886 | $1.48M | 0.1% | −151,114−50.4% | Reduced | – |
Options (13)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $84.6M | – |
| MRKMerck & Co., Inc. | Stock | $60.1M | – |
| ENPHEnphase Energy, Inc. | Stock | – | $42.2M |
| iShares Tr464287515 | EXPANDED TECH | $41.0M | – |
| State Street Technology Select Sector SPDR ETF81369Y803 | ETF | $31.0M | – |
| iShares Russell 2000 ETF464287655 | ETF | $24.1M | – |
| FVRRFiverr International Ltd. | ORD SHS | – | $19.2M |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $18.9M |
| Invesco Exch Traded FD Tr II46138G706 | SOLAR ETF | – | $18.8M |
| BIIBBiogen Inc. | COM | – | $17.3M |
| IONSIonis Pharmaceuticals Inc | COM | – | $7.44M |
| AGIOAgios Pharmaceuticals, Inc. | COM | – | $6.39M |
| ATERAterian, Inc. | Equity | – | $5.20M |
Sold out since Q1 2021 (73)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 200,000 | $12.6M | 1.2% | History |
| PANWPalo Alto Networks Inc | Stock | 32,300 | $10.4M | 1.0% | History |
| BOLTBolt Biotherapeutics, Inc. | COM | 241,000 | $7.93M | 0.7% | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 175,140 | $7.60M | 0.7% | History |
| Mohawk Group Hldgs Inc608189106 | COM | 251,015 | $7.41M | 0.7% | – |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 670,459 | $7.20M | 0.7% | – |
| Cyberark Software LtdM2682V108 | SHS | 55,000 | $7.11M | 0.7% | – |
| COGTCogent Biosciences, Inc. | COM | 762,569 | $6.70M | 0.6% | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 258,880 | $6.65M | 0.6% | History |
| IONSIonis Pharmaceuticals Inc | COM | 145,476 | $6.54M | 0.6% | History |
| Arya Sciences Acquisition CoG3166W106 | COM CL A | 400,000 | $5.51M | 0.5% | – |
| BIDUBaidu, Inc. | ADR | 25,000 | $5.44M | 0.5% | History |
| Rada Electr Inds LtdM81863124 | COM PAR NEW | 407,925 | $4.90M | 0.5% | – |
| Reinvent Technology PartnersG74847107 | SHS CL A | 468,012 | $4.68M | 0.4% | – |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 220,320 | $4.54M | 0.4% | History |
| MREOMereo BioPharma Group plc | SPON ADS | 1,312,415 | $4.42M | 0.4% | History |
| Farfetch Ltd30744W107 | ORD SH CL A | 80,000 | $4.24M | 0.4% | – |
| ORICOric Pharmaceuticals, Inc. | COM | 169,900 | $4.16M | 0.4% | History |
| Foresight Acquisition Corp34552Y205 | UNIT 01/29/2026 | 420,000 | $4.16M | 0.4% | – |
| IFRXInflaRx N.V. | COM | 1,000,000 | $3.90M | 0.4% | History |
| Catabasis Pharmaceuticals IN14875P206 | COM NEW | 1,294,000 | $3.74M | 0.3% | – |
| EWTXEdgewise Therapeutics, Inc. | COM | 100,000 | $3.25M | 0.3% | History |
| Longview Acquisition Corp. II54319Q204 | UNIT 99/99/9999 | 300,000 | $3.01M | 0.3% | – |
| GRTXGalera Therapeutics, Inc. | COM | 323,348 | $2.85M | 0.3% | History |
| DMRADamora Therapeutics, Inc. | COM | 448,016 | $2.72M | 0.3% | History |
| PHASPhaseBio Pharmaceuticals Inc | COM | 750,000 | $2.60M | 0.2% | History |
| IMVTImmunovant, Inc. | COM | 158,500 | $2.54M | 0.2% | History |
| SNCEScience 37 Holdings, Inc. | COM | 244,000 | $2.47M | 0.2% | History |
| FNCHFinch Therapeutics Group, Inc. | COM | 150,000 | $2.39M | 0.2% | History |
| CAMTCamtek Ltd | ORD | 79,746 | $2.38M | 0.2% | History |
| TILInstil Bio, Inc. | COM | 95,000 | $2.38M | 0.2% | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 198,260 | $2.10M | 0.2% | History |
| Highcape Cap Acquisition Cor42984L105 | COM CL A | 172,396 | $2.06M | 0.2% | – |
| ALITAlight, Inc. / Delaware | COM CL A | 200,000 | $2.01M | 0.2% | History |
| EQEquillium, Inc. | COM | 254,184 | $1.82M | 0.2% | History |
| GIGCAPITAL4 Inc37518G200 | UNIT 99/99/9999 | 175,000 | $1.73M | 0.2% | – |
| Starboard Value Acquisitn Co85521J109 | COM CL A | 170,937 | $1.70M | 0.2% | – |
| Pieris Pharmaceuticals Inc720795103 | COM | 650,000 | $1.67M | 0.2% | – |
| KDNYChinook Therapeutics, Inc. | COM | 101,666 | $1.58M | 0.1% | History |
| NSTBNorthern Star Investment Corp. II | COM CLASS A | 155,367 | $1.55M | 0.1% | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 70,000 | $1.54M | 0.1% | History |
| IMCRImmunocore Holdings plc | ADS | 36,000 | $1.53M | 0.1% | History |
| Forum Merger IV Corp349875203 | UNIT 03/15/2028 | 150,000 | $1.49M | 0.1% | – |
| Landcadia Holdings IV, Inc.51477A203 | UNIT 05/01/2025 | 150,000 | $1.49M | 0.1% | – |
| Alkuri Global Acquisition Corp.66981N202 | UNIT 01/01/2028 | 150,000 | $1.48M | 0.1% | – |
| BBIOBridgeBio Pharma, Inc. | COM | 23,890 | $1.47M | 0.1% | History |
| LRMRLarimar Therapeutics, Inc. | COM | 100,000 | $1.46M | 0.1% | History |
| GMDAGamida Cell Ltd. | SHS | 178,450 | $1.44M | 0.1% | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 5,530 | $1.19M | 0.1% | History |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 100,000 | $1.12M | 0.1% | History |
| Revolution Accelertn Acqu Co76156P106 | COM CL A | 109,994 | $1.11M | 0.1% | – |
| SWBKSwitchback II Corp | COM CL A | 103,698 | $1.02M | 0.1% | History |
| Falcon Capital Acquisitn Cor30606L108 | COM CL A | 100,010 | $997.0K | 0.1% | – |
| Mcap Acquisition Corp55282T208 | UNIT 02/18/2030 | 100,000 | $995.0K | 0.1% | – |
| VPC Impact Acqu Holdi III IN91835J207 | UNIT 99/99/9999 | 100,000 | $987.0K | 0.1% | – |
| VPC Impact Acquisition HldgG9460L100 | UNIT 03/05/2026 | 100,000 | $986.0K | 0.1% | – |
| 890 5th Ave Partners Inc28250A204 | UNIT 01/12/2026 | 98,828 | $983.0K | 0.1% | – |
| CNTBConnect Biopharma Holdings Ltd | ADS | 50,000 | $925.0K | 0.1% | History |
| Glass Houses Acquisition Cor37714P202 | UNIT 03/25/2028 | 89,884 | $902.0K | 0.1% | – |
| NVMINova Ltd. | COM | 8,556 | $779.0K | 0.1% | History |
| Live Oak Mobility Acquisi Co538126202 | UNIT 03/01/2028 | 75,000 | $749.0K | 0.1% | – |
| LABPLandos Biopharma, Inc. | COM | 70,000 | $674.0K | 0.1% | History |
| Spartan Acquisition Corp II846775104 | COM | 50,000 | $523.0K | <0.1% | – |
| Vectoiq Acquisition Corp II92244F208 | UNIT 99/99/9999 | 50,000 | $507.0K | <0.1% | – |
| Stratim Cloud Acquisition Corp.86309R206 | UNIT 03/05/2026 | 50,000 | $500.0K | <0.1% | – |
| Z-Work Acquisition Corp98880C201 | UNIT 99/99/9999 | 50,000 | $498.0K | <0.1% | – |
| EJF Acquisition Corp.G2955B117 | UNIT 03/10/2026 | 49,900 | $497.0K | <0.1% | – |
| Agile Growth Corp.G01202129 | UNIT 03/09/2026 | 50,000 | $496.0K | <0.1% | – |
| MDH Acquisition Corp55283P205 | UNIT 99/99/9999 | 31,000 | $308.0K | <0.1% | – |
| CM Life Sciences Inc18978W109 | COM CL A | 20,000 | $298.0K | <0.1% | – |
| Noble Rock Acquisition CorpG6546R127 | UNIT 01/31/2028 | 28,000 | $277.0K | <0.1% | – |
| Fintech Evolution Acquis GroG3R19A112 | UNIT 99/99/9999 | 25,000 | $247.0K | <0.1% | – |
| NBSENeuBase Therapeutics, Inc. | COM | 31,900 | $236.0K | <0.1% | History |